Ethical Compliance
ALKEM LABORATORIES.
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
1.3%
Debt
9.1%
Liquidity
11.1%
Revenue
Debt
Liquidity
1.3%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Export Incentives | ₹17.26 |
| Sale of Pharmaceuticals Products | ₹10,453.96 |
| Job Work Income | ₹58.07 |
| Scrap Sales | ₹18.33 |
| Budgetary Support Benefit Under Gst | ₹83.72 |
| Miscellaneous Income | ₹2.85 |
Questionable
INR Crores
Non Compliant
INR Crores
| Other Income | ₹162.65 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹162.65 |
| Total: | ₹162.65 |
| Total Revenue: | ₹12,667.58 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹162.65
₹12,667.58
= 1.3%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
